( October 22, 2025, 18:10 GMT | Official Statement) -- MLex Summary: Hikma Labs, West-Ward Columbus Inc., and West-Ward Pharmaceuticals moved to dismiss Walmart's amended US antitrust claims over an alleged price-fixing conspiracy on generic drugs. Walmart's "baseless and confusing allegations make clear that it did not bother to review the Motions to Dismiss filed in this MDL — including the ones filed in response to its original complaint," the defendants said in their motion filed to the Eastern District of Pennsylvania. Walmart improperly conflates West-Ward and Roxane — Hikma Labs was formerly known as Roxane Laboratories — as one single entity at the time of the conduct alleged, tries to make claims against West-Ward for products it did not manufacture, and fails to allege any actual facts sufficient to plead that Roxane participated in a conspiracy with generic drug manufacturers, the filing said.See attached document....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.